Acadia Healthcare Company, Inc.
Outcome
Acadia Healthcare paid $19.85 million to resolve False Claims Act allegations that it billed Medicare, Medicaid, and TRICARE for medically unnecessary inpatient behavioral health services and admitted patients who did not meet inpatient criteria; a concurrent New York Times investigation documented widespread unlawful patient detention practices at Acadia facilities in at least 12 states.
Details
Acadia Healthcare Company, Inc. — Medically Unnecessary Inpatient Admissions and Unlawful Patient Detention (2024)
Outcome: Acadia Healthcare Company, Inc. paid $19.85 million to resolve False Claims Act allegations covering medically unnecessary inpatient behavioral health admissions and improper lengths of stay. Concurrently, a New York Times investigation documented that Acadia facilities in at least 12 states were detaining patients against their will in violation of state law, with extended stays billed at up to $2,200 per day until insurance coverage was exhausted.
Acadia Healthcare Company, Inc. is a for-profit behavioral health company headquartered in Franklin, Tennessee, operating 54 inpatient psychiatric hospitals and numerous other behavioral health facilities across 19 states. The company was valued at approximately $7 billion at the time of the settlement.
The DOJ settlement, announced in September 2024, resolved allegations that between 2014 and 2017 Acadia knowingly submitted false claims to Medicare, Medicaid, and TRICARE for inpatient behavioral health services that were not reasonable or medically necessary. Acadia admitted beneficiaries who did not meet clinical criteria for inpatient treatment and failed to properly discharge patients when they no longer required inpatient-level care, generating improper lengths of stay. Three whistleblowers — Franka Tirado, Brian Snyder, and Jamie Thompson, all former Acadia employees — brought the qui tam lawsuit. The settlement required Acadia to pay $16,663,918 to the United States and $3,186,082 to the states of Florida, Georgia, Michigan, and Nevada.
Separately, a New York Times investigation published in September 2024 documented that Acadia used a range of tactics to extend patient stays for financial gain: exaggerating symptoms in communications to insurers, adjusting medication dosages to create apparent instability, and arguing that patients were not ready for discharge based on failure to complete meals or other minor behavioral indicators. In at least 12 states, patients, employees, and law enforcement personnel had reported to regulators that Acadia was detaining patients in ways that violated applicable law. Police officers in Georgia documented finding 16 patients held with "no excuses or valid reason." Inspectors in Tennessee found that a patient had not been checked on during the period for which monitoring was documented.
The pattern reflects systemic incentive misalignment at a large for-profit behavioral health chain where length-of-stay metrics were driven by insurance coverage duration rather than clinical need.
How Crucible Prevents This
Crucible clinical necessity documentation controls and admission-review gates would flag patterns of inpatient admissions where clinical documentation does not support medical necessity. Automated length-of-stay monitoring against clinical benchmarks, with escalation alerts when continued-stay criteria are not met in documented form, would prevent extended stays billed to exhaustion of insurance benefit. A patient rights compliance module tracking involuntary hold documentation, mandated timelines, and required physician attestations would surface unlawful detention patterns. Crucible's Corporate Integrity Agreement monitoring workflow supports ongoing DOJ-mandated compliance obligations.
Don't let this happen to your organization. See how Crucible works.
See How Crucible Works